Integrating laboratory and epidemiological techniques for population- based surveillance of HIV strains and drug resistance in Canada

Canadian Journal of Infectious Diseases

Volumn 11, Issue 2, 2000, Pages 74-80

  Jayaraman, Gayatri C ^a   Archibald, Chris P ^a   Lior, Lee ^a   Sutherland, Donald ^a  

^a LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; RISK FACTOR; SEXUAL TRANSMISSION; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION; VIRUS TYPING;

EID: 0034030640     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/412508     Document Type: Article

References (35)

1. Mansky LM, Temin HM. Lower in vivo mutation rate of HIV type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol 1995;69:5087-94.
2. Subbarao S, Schochetman G. Genetic variability of HIV-1. AIDS 1996;10(Suppl A):S13-S23.
3. Myers G, Korber B, Foley B, et al, eds. Human Retroviruses and AIDS. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences. Los Alamos: Theoretical Biology and Biophysics, 1996.
4. Gurtler L, Hauser PH, Eberle J, et al. A new subtype of HIV type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-5.
5. Simon F, Mauclere P, Roques P, et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998;4:1032-7.
6. Bernier L, Lamothe F, Bruneau J, et al. Analysis of HIV-1 sequence diversity in infected IDUs and MSM from Montreal. Eighth Annual Canadian Conference on HIV/AIDS Research, Vancouver, May 1-4, 1999. [Abst A104]
7. Montpetit ML, Ratnam S, Campbell C, Gleeson T, Donovan C, Tollefson J. Molecular epidemiological analysis of human immunodeficiency virus type 1 in Newfoundland, Canada. AIDS Res Hum Retroviruses 1998;14:1205-9.
8. Major C, Calzavara L, Cassol S, et al. Strain Surveillance and Genotyping, POLARIS, Ontario. Proceedings from the Joint HIV/AIDS and STD Meeting, Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control, Health Canada. Calgary, November 17-20, 1999. (In press)
9. Harrigan PR, Dong W, Alexander CS, et al. HIV transmission networks in seroconverting injection drug users. Eighth Annual Canadian Conference on HIV/AIDS Research. Vancouver, May 1-4, 1999. [Abst A103]
10. Montpetit M. HIV-1 subtype A in Canada. AIDS Res Hum Retroviruses 1995;11:1421-2.
11. Alexander C, Dong W, Chan K, et al. HIV non-B subtypes in a large North American cohort: prevalence and response to antiretroviral therapy. Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, January 31-February 3, 2000. [Abst 174]
12. Harrigan PR. HIV strain methods and results from the BC Centre for Excellence in HIV/AIDS. Proceedings from the Joint HIV/AIDS and STD Meeting, Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control, Health Canada. Calgary, November 17-20, 1999. (In press)
13. Kunanusont C, Foy HM, Kreiss JK, et al. HIV-1 subtypes and male-to-female transmission In Thailand. Lancet 1995;345:1078-83.
14. Hu DJ, Buve A, Baggs J, van der Groen G, Dondero TJ. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective. AIDS 1999;13:873-81.
15. Alexander C, Dong W, Chan K, et al. HIV non-B subtypes in a large North American cohort: prevalence and response to antiretroviral therapy. Seventh Conference on Retroviruses and Opportunistic Infections. San Francisco, January 31-February 3, 2000. [Abst 174].
16. Loussert-Ajaka I, Ly TB, Chaix ML, et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-4.
17. Boom R, Sol CJA, van der Noorda J, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;35:273-86.
18. HIV and AIDS in Canada. Surveillance Report to June 1999. Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control. Ottawa: Health Canada, November 1999.
19. HIV Prevalence and Incidence in Canada: 40,100 living with HIV infection and 4,200 new infections per year. HIV/AIDS and STD EpiUpdate. Bureau of HIV/AIDS, STD and TB, Laboratory Centre for Disease Control. Ottawa: Health Canada, May 1999.
20. Sonnerborg A, Durdevic S, Giesecke J, Sallberg M. Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res Hum Retroviruses 1997;13:343-5.
21. Dietrich U, Ruppach H, Gehring S, et al. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconverters. AIDS 1997;11:1532-3.
22. Arnold C, Barlow KL, Parry JV, Clewley JP. At least five HIV-1 sequence subtypes (A,B,C,D,A/E) occur in England. AIDS Res Hum Retroviruses 1995;11:427-9.
23. Fransen K, Buve A, Nkengasong JN, van der Groen G. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes. Lancet 1996;347:1403.
24. Gao F, Yue L, Hill SC, et al. HIV-1 sequence subtype D in the United States. AIDS Res Hum Retroviruses 1993;10:625-7.
25. Irwin KL, Pau CP, Lupo D, et al. Presence of human immunodeficiency virus (HIV) type 1 subtype A infection in a New York community with high HIV prevalence: A sentinel site for monitoring HIV genetic diversity in North America. Centers for Disease Control and Prevention-Bronx Lebanon HIV Serosurvey Team. J Infect Dis 1997;176:1629-33.
26. Weidle PJ, Ganea CE, Pienniazek D, et al. Prevalence of HIV-1 group M, non-B subtypes in a Bronx, New York community: A sentinel site for monitoring HIV genetic diversity in the United States. 12th World AIDS Conference. Geneva, June 28-July 3, 1998. [Abst 13225]
27. Zaidi I, Weinstock H, Kalish ML et al. Surveillance for HIV-1 subtypes in the United States, 1998-present. 7th Conference on Retroviruses and Opportunistic Infections. January 31-February 3, 2000. [Abst 215]
28. Brodine SK, Mascola JR, Weiss PJ, et al. Detection of diverse HIV-1 genetic subtypes in the USA. Lancet 1995;346:1198-9.
29. Artenstein AW, Copola J, Brown AE, et al. Multiple introductions of HIV-1 subtype E into the western hemisphere. Lancet 1995;346:1197-8.
30. Lasky M, Perret JL, Peeters M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997;11:43-51.
31. Sullivan P, Do AN, Lal R, et al. Surveillance for Group O HIV-1 infections among African-born persons in the United States 1995-1997. 12th National AIDS Conference. Geneva. June 28-July 3, 1998. [Abst 13103]
32. Alaeus A, Leitner T, Lidman K, Albert J. Most HIV-1 genetic subtypes have entered Sweden. AIDS 1997;11:199-202.
33. Lukashov W, Kuiken CL, Boer K, Goudsmit J. HIV type 1 subtypes in The Netherlands circulating among women originating from AIDS-endemic regions. AIDS Res Hum Retroviruses 1996;12:951-3.
34. Simon F, Loussert-Ajaka, I, Damond F, et al. HIV type 1 diversity in northern Paris, France. AIDS Res Hum Retroviruses 1996;12:1427-33.
35. Gehring S, Maayan S, Ruppach H, et al. Molecular epidemiology of HIV in Israel. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:296-305.